Annual Interest Expense
N/A
31 December 2023
Summary:
Celldex Therapeutics annual interest expense is not available.CLDX Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
N/A
01 September 2024
Summary:
Celldex Therapeutics quarterly interest expense is not available.CLDX Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
N/A
01 September 2024
Summary:
Celldex Therapeutics TTM interest expense is not available.CLDX TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLDX Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
CLDX Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time |
Celldex Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | $927.00 K(-41.2%) | $85.00 K(+553.8%) | $927.00 K(-22.3%) |
| Sept 2013 | - | $13.00 K(-97.5%) | $1.19 M(-23.6%) |
| June 2013 | - | $519.00 K(+67.4%) | $1.56 M(+7.4%) |
| Mar 2013 | - | $310.00 K(-11.7%) | $1.45 M(-7.8%) |
| Dec 2012 | $1.58 M(-12.2%) | $351.00 K(-7.9%) | $1.58 M(-5.2%) |
| Sept 2012 | - | $381.00 K(-7.3%) | $1.66 M(-3.3%) |
| June 2012 | - | $411.00 K(-5.1%) | $1.72 M(-1.3%) |
| Mar 2012 | - | $433.00 K(-1.1%) | $1.74 M(-2.9%) |
| Dec 2011 | $1.80 M | $438.00 K(0.0%) | $1.79 M(+6.1%) |
| Sept 2011 | - | $438.00 K(+0.9%) | $1.69 M(+6.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2011 | - | $434.00 K(-10.5%) | $1.59 M(+6.7%) |
| Mar 2011 | - | $485.00 K(+44.8%) | $1.49 M(+11.1%) |
| Dec 2010 | $1.34 M(+195.8%) | $335.00 K(+0.9%) | $1.34 M(-0.3%) |
| Sept 2010 | - | $332.00 K(-0.6%) | $1.34 M(+28.4%) |
| June 2010 | - | $334.00 K(-0.9%) | $1.04 M(+39.7%) |
| Mar 2010 | - | $337.00 K(-0.6%) | $748.00 K(+65.9%) |
| Dec 2009 | $452.00 K(+189.7%) | $339.00 K(+868.6%) | $451.00 K(+302.7%) |
| Sept 2009 | - | $35.00 K(-5.4%) | $112.00 K(+45.5%) |
| June 2009 | - | $37.00 K(-7.5%) | $77.00 K(+92.5%) |
| Mar 2009 | - | $40.00 K | $40.00 K |
| Dec 2008 | $156.00 K | - | - |
FAQ
- What is the all time high annual interest expense for Celldex Therapeutics?
- What is the all time high quarterly interest expense for Celldex Therapeutics?
- What is the all time high TTM interest expense for Celldex Therapeutics?
What is the all time high annual interest expense for Celldex Therapeutics?
Celldex Therapeutics all-time high annual interest expense is $1.80 M
What is the all time high quarterly interest expense for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly interest expense is $519.00 K
What is the all time high TTM interest expense for Celldex Therapeutics?
Celldex Therapeutics all-time high TTM interest expense is $1.79 M